Lessee, Operating Lease, Liability, to be Paid, Year Four in USD of Nuo Therapeutics, Inc. from Q2 2022 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
Nuo Therapeutics, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Four history and change rate from Q2 2022 to Q4 2023.
  • Nuo Therapeutics, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Four for the quarter ending 31 Dec 2023 was $21,283, a 74.3% decline year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Year Four, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year Four, YoY Quarterly Change (%)

Nuo Therapeutics, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Four (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2023 $21,283 -$61,422 -74% 31 Dec 2023 10-K 19 Apr 2024 2023 FY
Q3 2023 $21,284 -$61,421 -74% 30 Sep 2023 10-Q 20 Nov 2023 2023 Q3
Q2 2023 $21,283 -$61,422 -74% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 $21,283 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 $82,705 31 Dec 2022 10-K 17 Apr 2023 2022 FY
Q3 2022 $82,705 30 Sep 2022 10-Q 04 Nov 2022 2022 Q3
Q2 2022 $82,705 30 Jun 2022 10-Q/A 10 Aug 2022 2022 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.